Ventyx Biosciences Takes $114M
socalTECH
MARCH 9, 2021
Encinitas-based Ventyx Biosciences, a developer of immune modulators to treat inflammatory diseases and autoimmune disorders, said this morning that it has raised $114M in an equity funding round. The funding was led by venBio Partners, and also included Third Point, RTW Investments, LP, Janus Henderson Investors, Wellington Management, OrbiMed, Surveyor Capital (a Citadel company), Farallon Capital, Vivo Capital, Logos Capital, Qiming Venture Partners USA, Cormorant Asset Management, plus New S
Let's personalize your content